← Leaderboards
Henry J. Baker
Auburn University At Auburn
$898,542
Attributed
$898,542
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$898,542 · 2
By mechanism
R01$536,250 · 1
R21$362,292 · 1
Top collaborators
No co-investigators on record.
Most similar at Auburn University At Auburn
Same institution · by research overlap
- Heather L Gray-Edwards$4,340,720
- Douglas R Martin$3,447,411
- Bernhard Kaltenboeck$1,967,966
- Gregory S Pettit$1,484,484
- Mary F Forman$146,896
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyCatsBeta GalactosidaseNonhuman Therapy EvaluationGangliosidosisStem CellsStem Cell TransplantationIn Utero TransplantationBone MarrowDisease /Disorder ModelCell DifferentiationPolymerase Chain ReactionAdenoviridaeTransfection /Expression VectorCentral Nervous SystemComplementary DnaDisease /DisorderEmbryo /Fetus TherapyEnzymesGreen Fluorescent ProteinsLentivirusLysosomesNeuropathologyNewborn Animals
Grant awards (5)
Gene Therapy of the Gangliosidoses$181,250
R21 · FY2003 · HD
Stromal Stem Cells for Therapy of the Gangliosidoses$178,750
R01 · FY2003 · HL
Gene Therapy of the Gangliosidoses$181,042
R21 · FY2002 · HD
Stromal Stem Cells for Therapy of the Gangliosidoses$178,750
R01 · FY2002 · HL
Stromal Stem Cells for Therapy of the Gangliosidoses$178,750
R01 · FY2001 · HL